MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Clinical trial NCT06648434 · RECRUITING

Trial details

NCT number: NCT06648434
Sponsor: Washington University School of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Ductal Adenocarcinoma Pancreatic Cancer Cancer of the Pancreas

Start date: 2025-06-13
Primary completion: 2027-06-30
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.